Cargando…
Inflammatory phenotyping predicts clinical outcome in COVID-19
BACKGROUND: The COVID-19 pandemic has led to more than 760,000 deaths worldwide (correct as of 16th August 2020). Studies suggest a hyperinflammatory response is a major cause of disease severity and death. Identitfying COVID-19 patients with hyperinflammation may identify subgroups who could benefi...
Autores principales: | Burke, H., Freeman, A., Cellura, D. C., Stuart, B. L., Brendish, N. J., Poole, S., Borca, F., Phan, H. T. T., Sheard, N., Williams, S., Spalluto, C. M., Staples, K. J., Clark, T. W., Wilkinson, T. M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506817/ https://www.ncbi.nlm.nih.gov/pubmed/32962703 http://dx.doi.org/10.1186/s12931-020-01511-z |
Ejemplares similares
-
Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD
por: Burke, Hannah, et al.
Publicado: (2022) -
SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death
por: Tanner, Alex R, et al.
Publicado: (2021) -
Dysregulation of COVID-19 related gene expression in the COPD lung
por: Watson, Alastair, et al.
Publicado: (2021) -
Acquired immune responses to the seasonal trivalent influenza vaccination in COPD
por: Staples, K. J., et al.
Publicado: (2019) -
Re: 'Syndromic panels or “panel syndrome”? A perspective through the lens of respiratory-tract infections' by Zanella et al
por: Brendish, N.J., et al.
Publicado: (2020)